In the BioNIR Ridaforolimus-Eluting Coronary Stent System in Coronary Stenosis (BIONICS) and the NIREUS trials, the safety and efficacy of the novel ridaforolimus-eluting stent (RES) was evaluated, demonstrating the noninferiority… Click to show full abstract
In the BioNIR Ridaforolimus-Eluting Coronary Stent System in Coronary Stenosis (BIONICS) and the NIREUS trials, the safety and efficacy of the novel ridaforolimus-eluting stent (RES) was evaluated, demonstrating the noninferiority of this stent in comparison to zotarolimus-eluting stent (ZES), in
Keywords:
nireus trials;
zotarolimus eluting;
ridaforolimus;
bionics nireus;
eluting coronary;
comparison
Journal Title: Journal of the American College of Cardiology
Year Published: 2018
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: Journal of the American College of Cardiology
Year Published: 2018
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!